Day 1 Track Symposium

Interactive Case-Based Panel Discussion on Managing CMV In The High-Risk Transplant Recipient

Date/Time of Program
Thursday, 11 November 2021
90 Minute Symposium, (6:00-7:30PM SGT; 9:00-10:30PM AEDT; 5:00-6:30AM EST)


Together with Prof. Ban Hock Tan and Dr. Joe Sasadeusz, we will define the transplant recipient at high-risk of cytomegalovirus (CMV) infection and will discuss the challenges and unmet needs patients and clinicians face in managing CMV. The first part of the discussion will focus on risk factors and the burden of CMV infection or disease in transplant recipients. We will then touch upon current management options and the challenges they may place on patients. Lastly, the speakers will explore investigational agents for the management of CMV.


Agenda Speaker Time
Introduction 5 min
Define the transplant recipient at high-risk of CMV infection and discuss the unmet needs and challenges in the management of CMV infection with patient cases

  • Including risk factors and characterize the burden of CMV infection/disease in transplant recipients (including consequences of CMV infection/disease) – 1 patient case
  • Current therapy options, burden of treatment, including limitations of current/conventional antiviral therapies such as nephrotoxicity and myelosuppression – 1 patient case
Prof Tan Ban Hock 35 min
Explore investigational CMV infection management options and emerging clinical data

  • Including discussion of investigational agents for preemptive or prophylaxis therapy
  • 1 slide to touch upon earlier phase investigational agents
Dr. Joe Sasadeusz 35 min
Panel Discussion/ Q&A
Prof Tan Ban Hock / Dr Joe Sasadeusz
15 min


Dr Jasmine Chung
Singapore General Hospital
Dr. Chung is Consultant in Infectious Diseases. She completed her infectious diseases training in Singapore General Hospital (SGH), and went on to do her fellowship in Transplant Infectious Diseases at Duke University, Durham, NC, USA. Since her return, she consults regularly on the transplant infectious diseases service, haematology, as well as oncology unit. In addition to her interest in working with the immucompromised hosts, she is also actively involved in the hospital’s antimicrobial stewardship program, and is currently serving as the Director of the Antimicrobial Stewardship Unit.


Prof Tan Ban Hock
Singapore General Hospital, Dept. of Infectious Diseases
Dr. Tan graduated from the National University of Singapore and obtained his MRCP (Edinburgh) in 1995. He went on to train in infectious diseases in Singapore and at the Massachusetts General Hospital in Boston, Massachusetts, USA. He has been Head of Infectious Diseases and of Internal Medicine at SGH. He is currently Infectious Diseases Lead with SingHealth Transplant. He is currently President-elect of the Transplant Infections Disease Section of The Transplantation Society, and sits on the editorial board of Transplant Infectious Disease. He served for 9 years as co-chair of the Asia Fungal Working Group.
Dr. Tan has a keen interest in the study of infections in immunocompromised hosts and is particularly interested in infections in transplant recipients and febrile neutropenic patients.

Prof Joe Sasadeusz
University of Melbourne
Melbourne, Australia
CI Associate Professor Joe Sasadeusz is a clinician scientist with a national reputation in viral infections. He is an infectious diseases physician based at the Royal Melbourne Hospital with a cross appointment to the Alfred Hospital in Melbourne Australia. He is also a Fellow at the University of Melbourne. He undertook his advanced training in general medicine then infectious diseases training in Melbourne and then moved to the University of British Columbia in Vancouver Canada where he completed a PhD in the area of antiviral resistance. His background training is in medical virology. He also has a strong background in clinical trials and heads a clinical trial unit with a focus on viral infections at The Royal Melbourne Hospital.
He has a particular interest in infections in the immunocompromised host and is attached to the haematology and haematopoietic stem cell transplant units at the Royal Melbourne Hospital and VCCC. He has conducted over 50 clinical trials and has published over 100 articles in peer reviewed journals. He is also the current holder of an NHMRC grant in HIV-HBV coinfection looking at HBV cure strategies utilizing an international clinical cohort.